Product Reports Resources Pricing Login Book a demo

Versant Ventures

Venture Capital · Founded 1999 · San Francisco, United States

#345 Investor Ranking 2026 Top 2% of investors worldwide

Global healthcare investment firm

Website ↗LinkedIn ↗
172 Portfolio companies+19% in 5 years
23 Unicorns
4 Decacorns
339 Investments
Nov 2025 Last investment
01 · Knowledge graph
News Kurma Partners closes €215M Biofund IV, crosses €1B in assets under management Apr 23, 2026
02 · Exits

Versant Ventures’ biggest exits.

Portfolio companies that IPO’d or were acquired at $1B+, with the valuation recorded at exit and — for those still public — their value today. Exit events come from each company’s funding-round history; entry stage from Versant Ventures’ transaction record.

Jazz Pharmaceuticals
$108M IPO · 2007
Entered Series ANow $19BHealth
Smith & Nephew
IPO · 1999
Now $16BHealth
Glaukos
$415M IPO · 2015
Entered Series ANow $10BHealth
Insulet
IPO · 2007
Entered Series B+Now $10BHealth
Crinetics Pharmaceuticals
$391M IPO · 2018
Entered Series ANow $7.8BHealth
Inari Medical
$1.0B IPO · 2020
Entered Series ANow $4.9BHealth
Ambrx
$4.7B IPO · 2021
Entered Series B+Now $1.6BHealth
Akero Therapeutics
$433M IPO · 2019
Entered Series ANow $3.8BHealth
RayzeBio
$311M IPO · 2023
Entered Series ANow $3.7BHealth
CRISPR Therapeutics
$626M IPO · 2016
Entered Series ANow $3.6BHealth
OLO
$3.5B IPO · 2021
Entered Series B+Now $1.4BFood
CymaBay Therapeutics
IPO · 2014
Entered Series B+Now $3.5BHealth
03 · Portfolio analysis

Where Versant Ventures’ portfolio is concentrated.

Distribution of portfolio companies by headquarters country, sector, entry stage and current growth stage. Across all 172 portfolio companies. "Stage entered" is the first priced round the investor joined, derived from the investor’s transaction history.

By countryCount
  1. USA154
  2. Switzerland12
  3. Canada3
  4. France2
  5. UK2
  6. Cuba1
  7. Denmark1
  8. Ireland1
  9. Netherlands1
By sectorCount
  1. Health162
  2. Home Living4
  3. Fashion2
  4. Wellness Beauty2
  5. Energy1
  6. Enterprise Software1
  7. Fintech1
  8. Food1
  9. Hosting1
  10. Real Estate1
  11. Security1
  12. Semiconductors1
By stage enteredCount
  1. Series A99
  2. Series B+68
  3. Seed5
By growth stageCount
  1. Late Growth83
  2. Breakout Stage76
  3. Early Growth14
  4. Mature4
04 · Portfolio market map

Inside Versant Ventures’ portfolio.

The 60 highest-funded portfolio companies, of 172 tracked.

Century Therapeutics
Health
$272M
Crinetics Pharmaceuticals
Health · Unicorn
$7.8B
RayzeBio
Health · Unicorn
$3.7B
Ocular Therapeutix
Health · Unicorn
$1.5B
Vividion Therapeutics
Health · Unicorn
$1.5B
Ventus Therapeutics
Health
$280M
Halio
Energy
$500M
Ambrx
Health · Unicorn
$1.6B
Lycia Therapeutics
Health
$300M
Gritstone Oncology
Health
$1.6M
Chinook Therapeutics
Health
$184M
Jazz Pharmaceuticals
Health · Decacorn
$19B
Cameron Health
Health · Unicorn
$1.4B
Bright Peak Therapeutics
Health
$535M
Passage Bio
Health
BlueRock Therapeutics
Health · Unicorn
$1.0B
Monte Rosa Therapeutics
Health
$774M
Santa Ana Bio
Health
$172M
Intuity Medical
Health
$105M
Jnana
Health
$428M
Black Diamond Therapeutics
Health
$19M
Graphite Bio
Health
$197M
T-knife
Health
$440M
AcuFocus
Health
$36M
Vital Therapies
Health
$17M
Halio, Inc.
Real Estate
$400M
LENZ Therapeutics
Health
Nuvaira
Health
$60M
OLO
Food · Unicorn
$1.4B
Borealis Biosciences
Health
$750M
Abdera Therapeutics
Health
$341M
Monteris Medical
Health
$175M
Repare Therapeutics
Health
$2.0M
Clovis Oncology
Health
$264M
VectivBio
Health · Unicorn
$1.0B
Respicardia
Health
$234M
VenatoRx Pharmaceuticals
Health
$210M
Nouscom
Health
$334M
Capsida Biotherapeutics
Health
$560M
Insulet
Health · Decacorn
$10B
Pandion Therapeutics
Health · Unicorn
$1.9B
Audentes Therapeutics
Health
Akero Therapeutics
Health · Unicorn
$3.8B
Turnstone Biologics
Health
CymaBay Therapeutics
Health · Unicorn
$3.5B
Immune Design
Health
$300M
CRISPR Therapeutics
Health · Unicorn
$3.6B
Belharra Therapeutics
Health
$200M
Achaogen
Health
NeoVista
Hosting
$72M
Nested Therapeutics
Health
$360M
Gate Bioscience
Health
$260M
Minerva Surgical
Health
$32M
Skye Bioscience
Health
$1.5M
Standard Biotools
Health
Tarveda Therapeutics
Health
$150M
Alexza Pharmaceuticals
Health
$208M
Benvenue Medical
Health
$160M
iECURE, Inc.
Health
$260M
Oyster Point Pharmaceuticals
Health
$326M
05 · Portfolio founders

Where Versant Ventures’ portfolio founders come from.

105 founders across the 100 highest-funded portfolio companies — by current location, university attended, and the companies they worked at before founding. Sourced from the founder records the API links to each portfolio company.

LocationCount
  1. United States73
  2. Canada8
  3. Switzerland8
  4. Denmark5
  5. United Kingdom3
  6. France2
  7. Germany1
  8. Ireland1
  9. Italy1
  10. Netherlands1
UniversityCount
  1. Massachusetts Institute of Technology7
  2. Harvard University6
  3. Stanford University5
  4. University of California, Berkeley5
  5. University of Copenhagen4
  6. McGill University3
  7. Simon Fraser University3
  8. Yale University3
  9. Harvard Business School2
  10. King's College London2
Previous companyCount
  1. Alantos Pharmaceuticals7
  2. Genentech4
  3. Harvard University3
  4. Massachusetts Institute of Technology3
  5. Merck & Co.3
  6. Abbott2
  7. Amira Pharmaceuticals2
  8. Bristol-Myers Squibb2
  9. Broad Institute2
  10. Editas Medicine2
06 · Similar investors

Similar investors.

Peers the API surfaces as most similar by portfolio shape, with Dealroom investor rank and portfolio scale.

NEA
Venture Capital · Menlo Park
#36 rank 1,186 companies $2.5T portfolio
GV
Corporate · San Francisco
#74 rank 423 companies $914B portfolio
HTGF
Venture Capital · Bonn
#681 rank 578 companies $28B portfolio
Fidelity Investments
Private Equity · Boston
#7 rank 363 companies $6.1T portfolio
Khosla Ventures
Venture Capital · Menlo Park
#53 rank 856 companies $1.9T portfolio
MassChallenge
Accelerator · Boston
#10,963 rank 1,065 companies $20B portfolio
Bpifrance
Sovereign Wealth Fund · Maisons-Alfort
#94 rank 1,363 companies $165B portfolio
Y Combinator
Accelerator · San Francisco
#62 rank 7,127 companies $1.9T portfolio
07 · Key people

Key people at Versant Ventures.

Beckie Robertson
Beckie Robertson
Founder
 Carlo Rizzuto
Carlo Rizzuto
Managing Director
 Robin Praeger
Robin Praeger
CFO
 Kirk G. Nielsen
Kirk G. Nielsen
Managing Director
 Jerel Davis
Jerel Davis
Managing Director
 Clare Ozawa
Clare Ozawa
Managing Director
Source: Dealroom next-gen API — investor team endpoint.